Your session is about to expire
← Back to Search
CSD for Ventricular Tachycardia (PREVENT VT Trial)
PREVENT VT Trial Summary
This trial is examining whether surgery to rid the heart of nerves that trigger abnormal rhythms can prevent ICD shocks, which are painful and linked to reduced quality of life.
PREVENT VT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPREVENT VT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PREVENT VT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many willing test subjects are required for this experiment?
"This study needs 40 patients that meet the given conditions in order to proceed. People who want to help with this research can do so by enrolling at different sites, such as Johns Hopkins University or Vanderbilt University."
Does the FDA condone combining routine care with Cardiac Sympathetic Denervation?
"This routine care + Cardiac Sympathetic Denervation (CSD) intervention has been studied in Phase 3 trials, so it has received a safety score of 3 from our team."
Can people with the required medical conditions join this clinical trial at this time?
"That is correct. The clinical trial described on clinicaltrials.gov is looking for 40 patients from 4 different sites. The trial was posted on 7/26/2021 and was last updated on 8/31/2021."
Share this study with friends
Copy Link
Messenger